Statisticians are for more than clinical trials

被引：0

|

作者：

Walfish, S ^{[1
]}

机构：

[1] Stat Outsourcing Serv, Rockville, MD USA

来源：

BIOPHARM INTERNATIONAL | 2006年 / 19卷 / 02期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：66 / 66

页数：1

相关论文

共 50 条

[21] CONTROLLED CLINICAL-TRIALS - TODAYS CHALLENGES FOR STATISTICIANS AND DESIGNERS
BOISSEL, JP
CONTROLLED CLINICAL TRIALS, 1981, 1 (04): : 333 - 337
[22] Apremilast withdrawals more frequent in standard practice than in clinical trials
Schmutz, J. -L.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (04): : 309 - 310
[23] Making public and patient involvement in clinical trials more than aspirational
Hinson, Holly E.
Hamilton, Roy H.
Matchar, David B.
NEUROLOGY-CLINICAL PRACTICE, 2020, 10 (03) : 188 - 189
[24] Phase 0 (zero) clinical trials: More than zero benefit?
Schellens, Jan H. M.
EUROPEAN JOURNAL OF CANCER, 2009, 45 (05) : 728 - 729
[25] The role of medical physicists in clinical trials: More than quality assurance
Kron, Tomas
JOURNAL OF MEDICAL PHYSICS, 2013, 38 (03) : 111 - 114
[26] COMPARATIVE CLINICAL-TRIALS WITH HISTORICAL CONTROLS - STATISTICIANS VIEW
GEHAN, EA
BIOMEDICINE, 1978, 28 : 13 - 19
[27] The unblinding of statisticians in clinical trials: commentary on Iflaifel et al., Trials 2023
Parker, Richard A.
TRIALS, 2023, 24 (01)
[28] The unblinding of statisticians in clinical trials: commentary on Iflaifel et al., Trials 2023
Richard A. Parker
Trials, 24
[29] More on clinical trials
Litt, IF
JOURNAL OF ADOLESCENT HEALTH, 2001, 28 (06) : 441 - 442
[30] Authors' Rejoinder to Commentaries on 'Measurement in clinical trials: A neglected issue for statisticians?'
Senn, Stephen
STATISTICS IN MEDICINE, 2009, 28 (26) : 3223 - 3225

← 1 2 3 4 5 →